Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 35 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Pattern of pareses in 5q-spinal muscular atrophy.
Uzelac Z, Schwäble B, Dorst J, Rosenbohm A, Wollinsky K, Wurster CD, Steinbreier JS, Ludolph AC
Ther Adv Neurol Disord, 17:17562864241263420, 27 Aug 2024
Cited by: 0 articles | PMID: 39206217 | PMCID: PMC11350530
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.
Weiß C, Becker LL, Friese J, Blaschek A, Hahn A, Illsinger S, Schwartz O, Bernert G, Hagen MV, Husain RA, Goldhahn K, Kirschner J, Pechmann A, Flotats-Bastardas M, Schreiber G, Schara U, Plecko B, Trollmann R, Horber V, [...] SMArtCARE and Swiss-Reg-NMD study group
Lancet Reg Health Eur, 47:101092, 07 Oct 2024
Cited by: 1 article | PMID: 39434961 | PMCID: PMC11492610
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
Schwartz O, Vill K, Pfaffenlehner M, Behrens M, Weiß C, Johannsen J, Friese J, Hahn A, Ziegler A, Illsinger S, Smitka M, von Moers A, Kölbel H, Schreiber G, Kaiser N, Wilichowski E, Flotats-Bastardas M, Husain RA, Baumann M, [...] SMARTCARE study group
JAMA Pediatr, 178(6):540-547, 01 Jun 2024
Cited by: 4 articles | PMID: 38587854
Add to export list
Respiratory function in adult patients with spinal muscular atrophy treated with nusinersen - a monocenter observational study.
Wurster CD, Uzelac Z, Dreyhaupt J, Schuster J, Dorst J, Ludolph AC, Wollinsky K
Front Neurol, 15:1372674, 03 Apr 2024
Cited by: 0 articles | PMID: 38633535 | PMCID: PMC11021633
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, Mayer K, Weiland U, Herrmann C, Schuster J, Freischmidt A, Müller K, Siebert R, Bachhuber F, Simak T, Günther K, Fröhlich E, Knehr A, [...] Ludolph AC
EClinicalMedicine, 69:102495, 15 Feb 2024
Cited by: 10 articles | PMID: 38384337 | PMCID: PMC10878861
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeted proteomics upon Tofersen identifies candidate response markers for SOD1-linked amyotrophic lateral sclerosis
Steffke C, Baskar K, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, Reilich P, Regensburger M, German A, Günther R, Vidovic M, Petri S, Weishaupt JH, Meyer T, Hagenacker T, Grosskreutz J, Weyen U, Weydt P, Haarmeier T, [...] Catanese A
medRxiv, 24 Apr 2024
Cited by: 0 articles | PPR: PPR842568
Add to export list Preprint
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.
Günther R, Wurster CD, Brakemeier S, Osmanovic A, Schreiber-Katz O, Petri S, Uzelac Z, Hiebeler M, Thiele S, Walter MC, Weiler M, Kessler T, Freigang M, Lapp HS, Cordts I, Lingor P, Deschauer M, Hahn A, Martakis K, [...] Hagenacker T
Lancet Reg Health Eur, 39:100862, 06 Feb 2024
Cited by: 5 articles | PMID: 38361750 | PMCID: PMC10864329
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi.
Flotats-Bastardas M, Bitzan L, Grell C, Martakis K, Winter B, Zemlin M, Wurster CD, Uzelac Z, Weiß C, Hahn A
Front Neurol, 14:1269406, 13 Dec 2023
Cited by: 0 articles | PMID: 38162454 | PMCID: PMC10756901
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Staged treatment response in status epilepticus: Lessons from the SENSE registry.
Beuchat I, Novy J, Rosenow F, Kellinghaus C, Rüegg S, Tilz C, Trinka E, Unterberger I, Uzelac Z, Strzelczyk A, Rossetti AO
Epilepsia, 65(2):338-349, 21 Dec 2023
Cited by: 4 articles | PMID: 37914525
Add to export list
Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers-A Prospective, Cross-Sectional, Multi-Center Analysis.
Wohnrade C, Velling AK, Mix L, Wurster CD, Cordts I, Stolte B, Zeller D, Uzelac Z, Platen S, Hagenacker T, Deschauer M, Lingor P, Ludolph AC, Lulé D, Petri S, Osmanovic A, Schreiber-Katz O
Brain Sci, 13(1):110, 07 Jan 2023
Cited by: 4 articles | PMID: 36672091 | PMCID: PMC9857112
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy.
Stolte B, Schreiber-Katz O, Günther R, Wurster CD, Petri S, Osmanovic A, Freigang M, Uzelac Z, Leo M, von Velsen O, Bayer W, Dittmer U, Kleinschnitz C, Hagenacker T
Hum Gene Ther, 33(17-18):968-976, 07 Sep 2022
Cited by: 5 articles | PMID: 35943879
Add to export list
Refractory Status Epilepticus: Risk Factors and Analysis of Intubation in the Multicenter SENSE Registry.
Beuchat I, Rosenow F, Kellinghaus C, Trinka E, Unterberger I, Rüegg S, Sutter R, Tilz C, Uzelac Z, Rossetti AO, Strzelczyk A
Neurology, 99(16):e1824-e1834, 10 Aug 2022
Cited by: 11 articles | PMID: 35948449
Add to export list
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.
Binz C, Osmanovic A, Thomas NH, Stolte B, Freigang M, Cordts I, Griep R, Uzelac Z, Wurster CD, Kamm C, Siegler HA, Wieselmann G, Hermann A, Lingor P, Deschauer M, Ludolph AC, Meyer T, Günther R, Hagenacker T, [...] Schreiber-Katz O
Ann Clin Transl Neurol, 9(3):351-362, 22 Feb 2022
Cited by: 5 articles | PMID: 35191616 | PMCID: PMC8935281
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen.
Meyer T, Maier A, Uzelac Z, Hagenacker T, Günther R, Schreiber-Katz O, Weiler M, Steinbach R, Weyen U, Koch JC, Kettemann D, Norden J, Dorst J, Wurster C, Ludolph AC, Stolte B, Freigang M, Osmanovic A, Petri S, [...] Spittel S
Eur J Neurol, 28(8):2582-2595, 16 Jun 2021
Cited by: 13 articles | PMID: 33960080
Add to export list
Quality of Life in SMA Patients Under Treatment With Nusinersen.
Mix L, Winter B, Wurster CD, Platen S, Witzel S, Uzelac Z, Graf H, Ludolph AC, Lulé D
Front Neurol, 12:626787, 29 Mar 2021
Cited by: 11 articles | PMID: 33854472 | PMCID: PMC8039289
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA).
Mix L, Schreiber-Katz O, Wurster CD, Uzelac Z, Platen S, Gipperich C, Ranxha G, Wieselmann G, Osmanovic A, Ludolph AC, Petri S, Lulé D
Orphanet J Rare Dis, 16(1):10, 06 Jan 2021
Cited by: 12 articles | PMID: 33407722 | PMCID: PMC7789267
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Sustained Effort Network for treatment of Status Epilepticus (SENSE) - A multicenter prospective observational registry.
Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I, Rüegg S, Sutter R, Strzelczyk A, Tilz C, Uzelac Z, Rosenow F
Epilepsy Behav, 101(pt b):106553, 04 Nov 2019
Cited by: 2 articles | PMID: 31699661
Add to export list
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.
Wurster CD, Koch JC, Cordts I, Dreyhaupt J, Otto M, Uzelac Z, Witzel S, Winter B, Kocak T, Schocke M, Weydt P, Wollinsky K, Ludolph AC, Deschauer M, Lingor P, Tumani H, Hermann A, Günther R
Front Neurol, 10:1179, 07 Nov 2019
Cited by: 15 articles | PMID: 31787927 | PMCID: PMC6854024
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
Wurster CD, Steinacker P, Günther R, Koch JC, Lingor P, Uzelac Z, Witzel S, Wollinsky K, Winter B, Osmanovic A, Schreiber-Katz O, Al Shweiki R, Ludolph AC, Petri S, Hermann A, Otto M, MND-Net
J Neurol, 267(1):36-44, 24 Sep 2019
Cited by: 37 articles | PMID: 31552549
Add to export list
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.
Wurster CD, Günther R, Steinacker P, Dreyhaupt J, Wollinsky K, Uzelac Z, Witzel S, Kocak T, Winter B, Koch JC, Lingor P, Petri S, Ludolph AC, Hermann A, Otto M
Ther Adv Neurol Disord, 12:1756286419846058, 10 May 2019
Cited by: 31 articles | PMID: 31205491 | PMCID: PMC6535708
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE).
Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I, Rüegg S, Sutter R, Strzelczyk A, Tilz C, Uzelac Z, Rosenow F
Ann Neurol, 85(3):421-432, 04 Feb 2019
Cited by: 36 articles | PMID: 30661257
Add to export list
SENSE registry for status epilepticus.
Kellinghaus C, Rossetti AO, Trinka E, Lang N, Unterberger I, Rüegg S, Tilz C, Uzelac Z, Rosenow F
Epilepsia, 59 Suppl 2:150-154, 29 Aug 2018
Cited by: 4 articles | PMID: 30159884
Add to export list
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
Wurster CD, Winter B, Wollinsky K, Ludolph AC, Uzelac Z, Witzel S, Schocke M, Schneider R, Kocak T
J Neurol, 266(1):183-194, 20 Nov 2018
Cited by: 46 articles | PMID: 30460449
Add to export list
Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data: A Possible Proxy for Medical Prescription Behavior?
Gahr M, Uzelac Z, Zeiss R, Connemann BJ, Lang D, Schönfeldt-Lecuona C
J Clin Psychopharmacol, 35(6):681-685, 01 Dec 2015
Cited by: 8 articles | PMID: 26355849
Add to export list
Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.
Kellinghaus C, Lang N, Rossetti AO, Rüegg S, Tilz C, Trinka E, Unterberger I, Uzelac Z, Rosenow F
BMC Neurol, 15:230, 10 Nov 2015
Cited by: 6 articles | PMID: 26554812 | PMCID: PMC4641362
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 35 results

1 2

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Pattern of pareses in 5q-spinal muscular atrophy.

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.

Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.

Respiratory function in adult patients with spinal muscular atrophy treated with nusinersen - a monocenter observational study.

Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.

Targeted proteomics upon Tofersen identifies candidate response markers for SOD1-linked amyotrophic lateral sclerosis

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.

Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi.

Staged treatment response in status epilepticus: Lessons from the SENSE registry.

Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers-A Prospective, Cross-Sectional, Multi-Center Analysis.

Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy.

Refractory Status Epilepticus: Risk Factors and Analysis of Intubation in the Multicenter SENSE Registry.

Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.

Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen.

Quality of Life in SMA Patients Under Treatment With Nusinersen.

Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA).

Sustained Effort Network for treatment of Status Epilepticus (SENSE) - A multicenter prospective observational registry.

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.

Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.

Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.

Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE).

SENSE registry for status epilepticus.

Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.

Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data: A Possible Proxy for Medical Prescription Behavior?

Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.

Partnerships & funding